Stocks & Investing
Tue, July 6, 2010Mon, July 5, 2010Fri, July 2, 2010Thu, July 1, 2010Wed, June 30, 2010Tue, June 29, 2010Mon, June 28, 2010Fri, June 25, 2010Thu, June 24, 2010Wed, June 23, 2010Tue, June 22, 2010Mon, June 21, 2010Sun, June 20, 2010Fri, June 18, 2010Thu, June 17, 2010Wed, June 16, 2010Tue, June 15, 2010Mon, June 14, 2010Fri, June 11, 2010Thu, June 10, 2010Wed, June 9, 2010Tue, June 8, 2010Mon, June 7, 2010Sat, June 5, 2010Fri, June 4, 2010Thu, June 3, 2010Wed, June 2, 2010Tue, June 1, 2010Mon, May 31, 2010Fri, May 28, 2010CRH Medical provides significant new patient inquiries to physicians
Published in Stocks and Investing on Tuesday, June 15th 2010 at 3:22 GMT by Market Wire
VANCOUVER, June 15 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced today that its innovative marketing program is providing significant new patient inquiries to physicians listed on the Company's website who have been trained in the use of the Company's proprietary technology and methods known as the CRH O'Regan System(TM).
The Company's marketing program utilizes leading-edge search engine marketing and optimization strategies to attract hemorrhoid sufferers to its website, [ www.crhsystems.com ]. The website receives more than 17,000 first time visitors per month providing in excess of 1,000 new patient inquiries to the more than 295 participating physicians in 30 states. Access to hemorrhoid banding treatments using the CRH O'Regan System(TM) has dramatically increased since this time last year when the Company had 130 participating physicians.
Commenting on his experience working with CRH, Dr. Harry Sarles from Dallas, TX said, "CRH is the only medical products company that provides a comprehensive program which includes training, technology and new patients. We are very pleased with the patient outcomes and the number of new patients we have received as a result of our relationship with CRH Medical Corporation."
About CRH Medical Corporation:
CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.
The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.
For further information call Dean Linden, Corporate Communications, CRH Medical Corporation at 604.633.1440 or [ ir@crhmedcorp.com ]. Additional information may also be found by visiting the Company's website at [ www.crhmedcorp.com ] or the SEDAR website at [ www.sedar.com ].
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
